Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Conference News TCT 2019

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Michael O'Riordan

September 30, 2019

Presentation TCT 2019

Polymer-Free DES: Lessons Learned From Recent Trials

Presenter: Michael Maeng

September 26, 2019

Presentation TCT 2018

COMPASS Trial Revisited: Weighing Rivaroxaban Secondary Prevention vs DAPT After PCI

Presenter: Deepak L. Bhatt, Tullio Palmerini, Michael Maeng

September 23, 2018

Presentation TCT 2015

Case 4: Where Are the Guidewires? Two-Stent Treatment Guided by OCT

Presenter: Evald H. Christiansen, Andrejs Erglis, Michael Maeng

October 12, 2015

Presentation TCT 2014

Cases #2 and #3: Essentials of One-Stent and Two-Stent Technique Optimization

Presenter: Shao Liang Chen, Issam D. Moussa, Leif Thuesen, Michael Maeng

September 16, 2014

Presentation TCT 2014

Case #4: Swift and Safe DES for Side Branch Bail Out

Presenter: Evald H. Christiansen, George D. Dangas, Andrejs Erglis, Michael Maeng

September 14, 2014

Presentation TCT 2013

Case #1: One or Two Stents? Long-term Results from Nordic Baltic I Changed My Strategy!

Presenter: Michael Maeng

October 30, 2013

Presentation TCT 2013

TCT-12. Short Versus Long-Term Clinical Outcomes In A Randomised Comparison Of Zotarolimus- and Sirolimus-Eluting Coronary Stents

Presenter: Michael Maeng

October 29, 2013

Presentation TCT 2013

Stent edge dissections detected by Optical Coherence Tomography, incidence, predictors and 12-month outcome

Presenter: Rasmus Christensen, Niels Holm, Trine ?rh?j, Michael Maeng, Lars Krusell, Christian Terkelsen, Jouke Dijkstra, Anne Kaltoft, Steen Kristensen, Hans Erik B?tker, Leif Thuesen, Jens Flensted Lassen, Evald H?j Christiansen

January 31, 2013

Presentation TCT 2013

Intimal Hyperplasia and Vascular Remodeling after Everolimus-eluting and Sirolimus-eluting Stent Implantation in Diabetic Patients. The Randomized Diabetes and Drug-Eluting Sten...

Presenter: Lisbeth Antonsen, Lisette Okkels Jensen, Michael Maeng, Per Thayssen, Evald H?j Christiansen, Knud N?rregaard Hansen, Anne Kaltoft, Henrik Steen Hansen, Leif Thuesen, Jens Flensted Lassen

January 31, 2013

Presentation TCT 2012

TCT-55. Major Adverse Cardiac Events Associated with Discontinuation of Clopidogrel Treatment Within the First Year After Coronary Stent Implantation in Western Denmark

Presenter: Michael Maeng

October 23, 2012

Presentation TCT 2012

Outcomes After Revascularization with Everolimus- and Sirolimus Eluting Stents In Patients with Acute Coronary Syndromes. A Substudy of the SORT OUT IV Trial.

Presenter: Lisbeth Antonsen, Per Thayssen, Henrik Steen Hansen, Michael Maeng, Hans-Henrik Tilsted, Evald Hoej Christiansen, Knud Noerregaard Hansen, Hans Erik Boetker, Jan Ravkilde, Lars Krusell, Morten Madsen, Henrik Toft Soerensen, Leif Thuesen, Jens Flensted Lassen, Lisette Okkels Jensen

January 03, 2012

Presentation TCT 2012

Clinical Outcome in Diabetic Patients Treated for Coronary Bifurcation Lesions by Drug Eluting Stents - Pooled Analysis of the BBC ONE study and the Nordic Bifurcation Studies.

Presenter: Michael Maeng, David Hildick-Smith, Niels R. Holm, Adam de Belder, Matti Niemela, Nicholaus P. Curzen, Kari Kervinen, Andrejs Erglis, Indulis Kumsars, Keith G. Oldroyd, Paal Gunnes, Rodney H. Stables, Terje Steigen, Miles Behan, Jens F. Lassen, Leif Thuesen

January 03, 2012

Advertisement

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Polymer-Free DES: Lessons Learned From Recent Trials

COMPASS Trial Revisited: Weighing Rivaroxaban Secondary Prevention vs DAPT After PCI

Case 4: Where Are the Guidewires? Two-Stent Treatment Guided by OCT

Cases #2 and #3: Essentials of One-Stent and Two-Stent Technique Optimization

Case #4: Swift and Safe DES for Side Branch Bail Out

Case #1: One or Two Stents? Long-term Results from Nordic Baltic I Changed My Strategy!

TCT-12. Short Versus Long-Term Clinical Outcomes In A Randomised Comparison Of Zotarolimus- and Sirolimus-Eluting Coronary Stents

Stent edge dissections detected by Optical Coherence Tomography, incidence, predictors and 12-month outcome

Intimal Hyperplasia and Vascular Remodeling after Everolimus-eluting and Sirolimus-eluting Stent Implantation in Diabetic Patients. The Randomized Diabetes and Drug-Eluting Sten...

TCT-55. Major Adverse Cardiac Events Associated with Discontinuation of Clopidogrel Treatment Within the First Year After Coronary Stent Implantation in Western Denmark

Outcomes After Revascularization with Everolimus- and Sirolimus Eluting Stents In Patients with Acute Coronary Syndromes. A Substudy of the SORT OUT IV Trial.

Clinical Outcome in Diabetic Patients Treated for Coronary Bifurcation Lesions by Drug Eluting Stents - Pooled Analysis of the BBC ONE study and the Nordic Bifurcation Studies.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content